Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06437951
PHASE1

to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 Injection

Sponsor: Daewoong Pharmaceutical Co. LTD.

View on ClinicalTrials.gov

Summary

to evaluate the safety/tolerability and pharmacokinetics, and pharmacodynamics after intravenous DWP14012 injection in healthy participants

Official title: A Randomized, Double-blind, Placebo-controlled, Single/Multiple-dose, Phase 1 Clinical Trial to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics After Intravenous DWP14012 Injection in Healthy Participants

Key Details

Gender

All

Age Range

19 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2024-07

Completion Date

2025-05

Last Updated

2024-06-03

Healthy Volunteers

Yes

Interventions

DRUG

Fexuprazan Injection

20/40/80 mg

DRUG

Fexuprazan Injection placebo

20/40/80 mg

DRUG

Fexuprazan Injection_part 2

20mg

DRUG

Fexuprazan Injection_part 3

40mg

DRUG

Fexuprazan tablet

40mg